Bicycle Therapeutics plc Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Bicycle Therapeutics plc (BCYC) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $2.65 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-07-30
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.65M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.88M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.17M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $246.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $2.65M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $2.88M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $3.17M 10-K · filed 2026-03-17 |
| 2025-09-30 | $246.00K 10-Q · filed 2025-10-30 |
| 2025-06-30 | $364.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $494.00K 10-Q · filed 2025-05-01 |
| 2024-12-31 | $646.00K 10-K · filed 2025-02-25 |
| 2024-09-30 | $858.00K 10-Q · filed 2024-10-31 |
| 2024-06-30 | $1.05M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.28M 10-Q · filed 2024-05-02 |
| 2023-09-30 | $1.80M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.07M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $2.62M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.03M 10-K · filed 2023-02-28 |
| 2022-09-30 | $2.15M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.54M 10-Q · filed 2022-08-04 |
| 2020-03-31 | $245.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $208.00K 10-K · filed 2020-03-10 |
| 2019-09-30 | $460.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $402.00K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |